Entity Common Stock, Shares Outstanding of CytomX Therapeutics, Inc. from 19 Nov 2015 to 31 Oct 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
CytomX Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 19 Nov 2015 to 31 Oct 2025.
  • CytomX Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 31 Oct 2025 was 169,435,395, a 117% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

CytomX Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 169,435,395 +91,176,516 +117% 31 Oct 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 164,912,906 +86,795,305 +111% 31 Jul 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 80,621,293 +12,899,635 +19% 30 Apr 2025 10-Q 12 May 2025 2025 Q1
Q3 2024 78,258,879 +11,269,975 +17% 31 Oct 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 78,117,601 +11,349,822 +17% 29 Jul 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 67,721,658 +1,382,720 +2.1% 29 Feb 2024 10-K 11 Mar 2024 2023 FY
Q3 2023 66,988,904 +904,537 +1.4% 31 Oct 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 66,767,779 +817,537 +1.2% 31 Jul 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 66,338,938 +940,583 +1.4% 30 Apr 2023 10-Q 09 May 2023 2023 Q1
Q3 2022 66,084,367 +835,251 +1.3% 31 Oct 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 65,950,242 +793,239 +1.2% 29 Jul 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 65,398,355 +387,225 +0.6% 29 Apr 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 65,392,758 +608,403 +0.94% 31 Jan 2022 10-K/A 27 Mar 2023 2021 FY
Q3 2021 65,249,116 +19,024,714 +41% 31 Oct 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 65,157,003 +18,964,777 +41% 31 Jul 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 65,011,130 +19,087,925 +42% 30 Apr 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 64,784,355 +19,217,804 +42% 02 Feb 2021 10-K 24 Feb 2021 2020 FY
Q3 2020 46,224,402 +790,238 +1.7% 31 Oct 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 46,192,226 +782,758 +1.7% 31 Jul 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 45,923,205 +611,741 +1.4% 30 Apr 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 45,566,551 +455,269 +1% 31 Jan 2020 10-K 27 Feb 2020 2019 FY
Q3 2019 45,434,164 +427,060 +0.95% 31 Oct 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 45,409,468 +445,776 +0.99% 31 Jul 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 45,311,464 +6,700,306 +17% 30 Apr 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 45,111,282 31 Jan 2019 10-K 27 Feb 2019 2018 FY
Q3 2018 45,007,104 +6,598,478 +17% 02 Nov 2018 10-Q 06 Nov 2018 2018 Q3
Q2 2018 44,963,692 +8,096,325 +22% 06 Aug 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 38,611,158 +2,092,974 +5.7% 05 Mar 2018 10-K 07 Mar 2018 2017 FY
Q3 2017 38,408,626 +2,006,280 +5.5% 03 Nov 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 36,867,367 +578,954 +1.6% 04 Aug 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 36,518,184 +440,311 +1.2% 28 Feb 2017 10-K 02 Mar 2017 2016 FY
Q3 2016 36,402,346 01 Nov 2016 10-Q 03 Nov 2016 2016 Q3
Q2 2016 36,288,413 01 Aug 2016 10-Q 03 Aug 2016 2016 Q2
Q1 2016 36,077,873 02 Mar 2016 10-K 07 Mar 2016 2015 FY
Q4 2015 36,024,292 19 Nov 2015 10-Q 23 Nov 2015 2015 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.